85results about How to "Control blood sugar levels" patented technology

The present invention relates to a herbal health protective, promotive and disease preventive nutraceutical herbal formulation(s) for diabetics, and also relates to a process for the preparation of a herbal health protective, promotive and disease preventive nutraceutical herbal formulation as food supplement to ameliorate the general health of diabetics, said formulation comprises the base product of microwave roasted seed powders mixture from selected genera of Glycine, Cicer, Phaseolus, Cyamompsis, Mucuna, Hordeum, Amaranthus and Fagopyrum, fortified with herbs / medicinal plants used are selected from the genera of Gymnema, Momordica, Syzgium, Pterocarpus, Trigonella, Cinnamomum, Withania, Coccinia, Pueraria, Asparagus, Boerhaavia and Aegle and also some other ingredients like Piper longum, Chlorophytum tuberosum, Curcuma longa and Elettaria cardamomum were also added to get the final nutraceutical product(s); the nutraceuticals are with optimum nutrition, non toxic, natural herbal plant products, easy to digest, have health protective and promotive properties to ameliorate the general health and vigor of diabetics.

The invention relates to a diabetes treatment composition based on traditional Chinese medicine nutritional therapy and application thereof, wherein the diabetes treatment composition mainly comprisesvarious natural materials including medicinal and edible materials. The diabetes treatment composition is a low-GI composition, comprising various compound ingredients which may present through carbohydrates, fats and dietary fiber; by usage each day, the dietary fiber in the composition accounts for 10-40 g; the diabetes treatment composition has the total energy of 400-1300 calories, wherein energy provided according to the present quantity of carbohydrates is 15-45% of the total energy of the composition herein; energy provided according to the present quantity of fat is 40-80% of the total energy of the composition, wherein the mass of unsaturated fatty acids is 50-80% of total mass of fat. The composition provided herein lays emphasis on the here-low three-high structure of low GI, low calorie, low available carbohydrates, high unsaturated fatty acids, high dietary fiber and high homology of medicine and food; the intermittent fasting means helps reduce the glucose level of a diabetic patient effectively.

A nutritional composition for controlling blood sugar level comprising a protein, a lipid and a carbohydrate, wherein energy percentages supplied by the protein, lipid and carbohydrate are 10 to 25%, 20 to 35% and 40 to 60%, respectively; and oleic acid in the lipid energy percentage is 60 to 90% and palatinose and / or trehalulose in the carbohydrate energy percentage is 60 to 100%.The composition is useful as an oral or tube feeding nutrient for nutritional management or blood sugar level control of patients suffering from diabetes and glucose intolerance, or for obesity prevention, a therapeutic diet, a diet for diabetic patients at home, an obesity preventive diet or a food with health claims.

Gurmarin containing compositions are useful for the treatment of diabetes. Glucose metabolism in a human patient is regulated by gurmarin-containing dosage forms that contain optionally a non-metabolizable polysaccharide such as the exudate of Sterculia urens.

The invention discloses hyperglycosylated Extendin-4, fusion protein of analogue thereof, and a preparation method and the application of fusion protein. The fusion protein comprises Extendin-4, the analogue of the Extendin-4, a flexible peptide joint, at least one human chorionic gonadotropin beta carboxyl terminal peptide rigid unit and a human immunoglobulin Fc fragment. The invention also discloses the preparation method and the application of the fusion protein. The fusion protein has optimal biological activity, obviously prolonged circulation half-time, lowered immunogenicity and improved bioavailability. The fusion protein can be used for treating diabetes, obesity and other diseases benefited by lowering fasting plasma glucose, inhibiting stomach and / or bowel movement and inhibiting and / or bowel evacuation or inhibiting food intake.

The invention discloses hair blackening, beauty maintaining and young keeping medicinal food applicable to diabetes patients. The medicinal food comprises the following raw materials: in parts by weight, 500-1500 parts of yak tripe, 80-100 parts of valerian root powder, 80-100 parts of grape seeds, 80-100 parts of donkey-hide gelatin, 40-60 parts of common yam rhizomes, 30-50 parts of black sesame, 6-18 parts of prepared fleece flower roots, 12-36 parts of rehmannia rhizomes, 6-18 parts of corn stigma and the like. The hair blackening, beauty maintaining and young keeping medicinal food disclosed by the invention takes the yak tripe, valerian roots, the grape seeds and the donkey-hide gelatin as the monarch, and is based on the traditional Chinese medicine composition principle and combined with the latest achievement of modern pharmacological studies, so that scientificity and reasonability of the compatibility of the medicine materials are guaranteed. The medicinal food can replenish qi, enrich the blood, promote circulation, remove stasis, enrich yin and nourish kidney, invigorate the spleen and benefit the stomach, is beneficial to organism immunity improvement, and recuperates the appearance from the inside, has special effects of blood glucose reduction, antioxidation, aging resistance, hair blackening, beauty maintaining, young keeping and female hormone level adjustment, and is particularly suitable for being eaten daily by adult female diabetes patients.

The present invention aims to provide a novel agent for treating and / or preventing diabetes which agent can not only control a blood sugar level but also fundamentally treat a patient with type I diabetes suffering from destruction of cells and a patient with type II diabetes suffering from dysfunction in insulin secretion. The present invention provides an agent for treating and / or preventing diabetes, the agent containing retinoic acid as an active ingredient. Retinoic acid incorporated as an active ingredient may be all-trans retinoic acid, an isomer thereof, a derivative thereof, a salt thereof or a prodrug thereof. Retinoic acid may be incorporated singly. Alternatively, composite particles of retinoic acid and an appropriate inorganic or organic substance are prepared, and the retinoic acid composite particles may be incorporated.

The invention discloses an Exendin-4 analogue fused with a human IgG2 Fc variation and a preparation method of the Exendin-4 analogue. The circulating half-life period of the fusion protein is remarkably prolonged, and the biological availability is greatly improved. The fusion protein can be used for treating diabetes, obesity and other diseases that are benefited by lowering plasma glucose, inhibiting gastric and / or intestinal motion and inhibiting gastric and / or intestinal emptying or inhibiting food intake.

A method to estimate the variation of blood glucose concentration in a patient without blood sampling. The method can be implemented by measuring metabolic parameters including heat dissipation by conduction, percentage oxygen content of expired air and volume per minute of expired air. These parameters are used to calculate estimated blood glucose variation. The method can be used for a blood glucose change monitor or a teaching device for the lifeway of normal, prediabetes and II-diabetes people.